NCT03600142

Brief Summary

This study will pilot test a brief, scalable intervention called Maisha (Swahili for life), to address HIV stigma for women presenting to antenatal care in Tanzania and male partners who accompany them. The intervention will include: 1) a video and brief counseling that addresses HIV stigma at the start of the ANC visit (prior to HIV testing), and 2) two stigma-based counseling sessions for individuals who are HIV infected, building on the video content to provide emotional support, promote acceptance, address stigma, and reinforce care engagement. The primary intervention outcome is engagement in PMTCT care among women who are HIV infected. The investigators will also examine HIV stigma outcomes (enacted, anticipated, internalized) among all groups of participants, including individuals who are already established on ART and indiviudals who are HIV uninfected.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,539

participants targeted

Target at P75+ for not_applicable hiv-infections

Timeline
Completed

Started Apr 2019

Shorter than P25 for not_applicable hiv-infections

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 16, 2018

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 26, 2018

Completed
9 months until next milestone

Study Start

First participant enrolled

April 8, 2019

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2020

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

September 20, 2021

Completed
Last Updated

March 10, 2022

Status Verified

February 1, 2022

Enrollment Period

11 months

First QC Date

July 16, 2018

Results QC Date

June 24, 2021

Last Update Submit

February 27, 2022

Conditions

Keywords

StigmaHIVCounselingTanzaniaPregnancyCognitive-behavioral therapyRetention in carePrevention of mother to child transmission

Outcome Measures

Primary Outcomes (2)

  • HIV Care Engagement (Female HIV-infected Participants Only)

    For HIV-infected female participants, retention in care will be assessed via medical record review, with retention defined as having no more than a 60 day gap between PMTCT visits at the study clinic, or having record of an official transfer to another clinic.

    Post-assessment (3 months after enrollment)

  • Attitudes Toward People Living With HIV, Blame/Judgement Subscale (HIV-uninfected Participants Only)

    Self-report, measured by a modified version of personal and attributed stigma scales (Visser, Kershaw, Makin, \& Forsyth, 2008) Scoring: 6 items. Item scores range from 0-3 (Strongly Disagree to Strongly Agree). Item responses are totaled for a summary score. Total scores range 0-18, with higher scores indicating greater stigma.

    Post-assessment (3 months after enrollment)

Other Outcomes (1)

  • Quality Assurance (QA Data)

    Post-assessment (3 months after enrollment)

Study Arms (2)

Standard of Care (SoC)

NO INTERVENTION

Participants randomized to the control condition will receive the standard HIV counseling protocol in the clinic, which is administered by clinic nurses. According to the Tanzania PMTCT guidelines, HIV pre-test counseling should provide education about HIV and prepare a woman (and her partner, if present) for HIV testing. For anyone who tests positive for HIV, counseling should help the woman/couple to accept an HIV test result and discuss implications for treatment.

SoC + stigma counseling (Maisha)

EXPERIMENTAL

Participants randomized to the intervention condition will receive the SoC counseling plus Maisha, a brief, scalable, theory-based counseling intervention that addresses HIV stigma at entry into antenatal care. Maisha involves a video delivered to all women prior to HIV testing, and, if a woman tests positive for HIV, two counseling sessions. If a male partner is present with the women, he may also be enrolled and participate in the first two counseling sessions together with the woman.

Behavioral: Mashia

Interventions

MashiaBEHAVIORAL

Maisha is a brief, scalable, theory-based counseling intervention that addresses HIV stigma at entry into antenatal care. The intervention will be developed in a formative phase and includes 1) a video and counseling session prior to HIV testing that addresses HIV stigma, and 2) two post-test HIV counseling sessions for HIV-infected individuals, building on the video content to provide emotional support, address stigma, and reinforce the value of care engagement.

SoC + stigma counseling (Maisha)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • If female: Pregnant and attending first antenatal care (ANC) appointment for the current pregnancy at one of the two study sites
  • If male: Accompanying an enrolled woman to her first ANC appointment.

You may not qualify if:

  • Impaired mental status
  • Does not speak Swahili

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kilimanjaro Christian Medical Centre

Moshi, Tanzania

Location

Related Publications (4)

  • Watt MH, Knettel BA, Knippler ET, Kisigo G, Ngocho JS, Renju J, Rogathi J, Sao SS, Minja L, Osaki H, Mwamba RN, Mmbaga BT. The development of Maisha, a video-assisted counseling intervention to address HIV stigma at entry into antenatal care in Tanzania. Eval Program Plann. 2020 Dec;83:101859. doi: 10.1016/j.evalprogplan.2020.101859. Epub 2020 Aug 5.

    PMID: 32795711BACKGROUND
  • Watt MH, Minja L, Knettel BA, Mwamba RN, Osaki H, Ngocho JS, Kisigo GA, Renju J, Vissoci JRN, Sao SS, Mmbaga BT. Pilot Outcomes of Maisha: An HIV Stigma Reduction Intervention Developed for Antenatal Care in Tanzania. AIDS Behav. 2021 Apr;25(4):1171-1184. doi: 10.1007/s10461-020-03093-9. Epub 2020 Nov 12.

  • Cohen SR, Marchand V, Calkins K, Stephens MJ, Barabara ML, Minja LM, Olomi GA, Mlay J, Mlay PS, Hanson OR, Mmbaga BT, Watt MH. Participatory simulation training design: The MAMA interprofessional team-training program for obstetric care of pregnant individuals living with HIV in Tanzania. Eval Program Plann. 2025 Jun;110:102550. doi: 10.1016/j.evalprogplan.2025.102550. Epub 2025 Jan 31.

  • Watt MH, Knippler ET, Minja L, Kisigo G, Knettel BA, Ngocho JS, Renju J, Osaki H, Mwamba R, Rogathi JJ, Mmbaga BT. A counseling intervention to address HIV stigma at entry into antenatal care in Tanzania (Maisha): study protocol for a pilot randomized controlled trial. Trials. 2019 Dec 30;20(1):807. doi: 10.1186/s13063-019-3933-z.

MeSH Terms

Conditions

HIV InfectionsSocial Stigma

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesSocial BehaviorBehavior

Results Point of Contact

Title
Dr. Melissa Watt
Organization
University of Utah

Study Officials

  • Melissa Watt, PhD

    University of Utah

    PRINCIPAL INVESTIGATOR
  • Blandina Mmbaga, MD, PhD

    Kilimanjaro Christian Medical Centre

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Population Health Sciences

Study Record Dates

First Submitted

July 16, 2018

First Posted

July 26, 2018

Study Start

April 8, 2019

Primary Completion

March 15, 2020

Study Completion

March 15, 2020

Last Updated

March 10, 2022

Results First Posted

September 20, 2021

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will share

The data from the formative and pilot trial work in this R21 will be shared within the constraints required for the protection of confidentiality for study subjects. With a data transfer agreement from our Institutional Review Board, the investigators are willing to share raw data with researchers and program leaders from other institutions.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
Data will be shared starting 6 months after publication.
Access Criteria
Data will be shared with investigators who are interested in secondary data analysis or inclusion in meta-analyses. The investigators will work with individuals requesting data access to put in place an appropriate data transfer agreement. The study PI will review all requests for data sharing.

Locations